Operating income increased 41.9%
Operating income changed +41.9% from the comparable as-filed period.
-$29.0M→-$16.8M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SEPN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 2428831 bp higher
Operating margin changed +2428831 basis points from the comparable as-filed period.
-24351.26%→-62.95%2 prior comparisons
Research & development increased 58.3%
Research & development changed +58.3% from the comparable as-filed period.
$22.2M→$35.1M2 prior comparisons
Cash & equivalents decreased 55.3%
Cash & equivalents changed -55.3% from the comparable as-filed period.
$189.3M→$84.7M2 prior comparisons
Stock-based compensation increased 181.0%
Stock-based compensation changed +181.0% from the comparable as-filed period.
$1.8M→$5.1M2 prior comparisons
Capex / revenue moved 4874 bp lower
Capex / revenue changed -4874 basis points from the comparable as-filed period.
48.74%→0.00%2 prior comparisons
Current liabilities increased 424.3%
Current liabilities changed +424.3% from the comparable as-filed period.
$15.1M→$79.3M3 prior comparisons
Total assets increased 36.5%
Total assets changed +36.5% from the comparable as-filed period.
$415.2M→$566.7M3 prior comparisons
SBC / revenue moved 149868 bp lower
SBC / revenue changed -149868 basis points from the comparable as-filed period.
1517.65%→18.97%2 prior comparisons
Revenue changed across a low base
Revenue changed +22375.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$119,000→$26.7M2 prior comparisons
Free-cash-flow proxy decreased 9.0%
Free-cash-flow proxy changed -9.0% from the comparable as-filed period.
-$20.3M→-$22.2M3 prior comparisons
Current ratio decreased 77.4%
Current ratio changed -77.4% from the comparable as-filed period.
22.09→4.993 prior comparisons
Free-cash-flow margin moved 1701371 bp higher
Free-cash-flow margin changed +1701371 basis points from the comparable as-filed period.
-17096.64%→-82.92%2 prior comparisons
Operating cash-flow margin moved 1696497 bp higher
Operating cash-flow margin changed +1696497 basis points from the comparable as-filed period.
-17047.90%→-82.92%2 prior comparisons
R&D / revenue moved 1851402 bp lower
R&D / revenue changed -1851402 basis points from the comparable as-filed period.
18645.38%→131.35%2 prior comparisons
Working capital / assets moved 2092 bp lower
Working capital / assets changed -2092 basis points from the comparable as-filed period.
76.83%→55.91%3 prior comparisons
Current assets increased 18.6%
Current assets changed +18.6% from the comparable as-filed period.
$334.1M→$396.2M3 prior comparisons
Operating cash flow decreased 9.3%
Operating cash flow changed -9.3% from the comparable as-filed period.
-$20.3M→-$22.2M3 prior comparisons
Trade receivables changed across a low base
Trade receivables changed +7953.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$151,000→$12.2M3 prior comparisons
Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period.
$58,000→$03 prior comparisons
Receivables / revenue moved 8143 bp lower
Receivables / revenue changed -8143 basis points from the comparable as-filed period.
126.89%→45.46%2 prior comparisons
Shares outstanding increased 4.7%
Shares outstanding changed +4.7% from the comparable as-filed period.
44,585,135→46,676,9473 prior comparisons
Working capital decreased 0.7%
Working capital changed -0.7% from the comparable as-filed period.
$319.0M→$316.8M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.